1365267-27-1 ensartinib

Svojstva

Izgled bijeli do bijeli prah
Točka ključanja: 695,1 ± 55,0 stupnjeva
Gustoća 1,428 ± 0,06 g/cm3
Temp za pohranu . Skladištenje na -20 stupnju
 

Prijava:

Ensartinib is mainly used to treat ALK positive non-small cell lung cancer (NSCLC), especially in patients who have progressed or become intolerant after previous treatment with crizotinib. Ensartinib is an oral small molecule tyrosine kinase inhibitor that can specifically inhibit the activity of ALK (anaplastic lymphoma kinase), thereby blocking the growth and division signals of Stanice tumora
 

Sinonimi:

1365267-27-1

X-376

(R) -6- amino -5- (1- (2, 6- dikloro -3- fluorofenil) ethoxy) -n-({{8 }} ({4- metilpiperazin -1- karbonil) fenil) piridazin -3- karboksamid

6- amino -5- [(1r) -1- (2, 6- dikloro -3- fluorofenil) ethoxy] -n-[{{9 }} ({4- metilpiperazin -1- karbonil) fenil] piridazin -3- karboksamid

3- piridazinecarboxamide, 6- amino -5- ((1r) -1- (2, 6- dikloro -3- fluorofenil) ethoxy) -n-({}} {{{{{{{{{{{{{{{{{{{{{{{)

X -376 (Standard)

Popularni tagovi: 1365267-27-1 ensartinib, Kina 1365267-27-1 Proizvođači ensartiniba, dobavljači, Šifriranje podataka API, Provjera podataka API -ja, Integracija API Healthcare API, Integracija API zaliha API, API integracija srednjeg poslovnog API-ja, API integracija virtualne stvarnosti